KFF’s 2026 tracking poll found that many U.S. adults have heard common vaccine myths, including false claims about MMR, COVID ...

For the first time, a research team has demonstrated an artificial intelligence semiconductor technology that integrates the ...

The New Brunswick Health Council released its 2025 primary care survey Tuesday, which showed that 73 per cent of respondents ...

In a Realmeter poll, President Lee Jae-myung's approval rating stood at 46.7%. This is the first time since last June, after taking office, that the president's approval rating in a Realmeter survey ...

The Iranian government has submitted its response to the peace proposal from the U.S., according to the Islamic Republic News Agency. The state-owned outlet reported, citing a source familiar with the ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. Last ...

Dr. Weatherby is the director of the Digital Theory Lab at New York University. Dr. Recht is a professor of electrical engineering and computer sciences at the University of California, Berkeley. See ...

Update: Article updated with comments from security researchers who believe this should not be considered a vulnerability. Update 2: CERT has retracted its bulletin and MITRE has rejected the CVE on ...

Travis is working on his dunk technique in this video, doing random dunks. It was a cold day, so he focused on jump and dunk technique. Donald Trump reacts to Joe Kent resigning over Iran war McDonald ...

Dallas police are considering leveraging technology and a public-awareness campaign as they look for ways to curb random gunfire across the city. Police briefed the City Council's Public Safety ...

Dallas Police reported the fewest number of random gunfire calls in four years in 2025, according to new data shared with the Dallas City Council on Monday. During its presentation to the Public ...

Erdafitinib or Erdafitinib Plus Cetrelimab for Patients With Metastatic Urothelial Carcinoma and FGFR Alterations: Final Results From the Phase II NORSE Study This multicenter open-label RCT enrolled ...